REFERENCES
- Jamieson WG, Pliagus G, Marchuk S, Effect of antibiotic and fluid resuscitation upon survival time in experimental intestinal ischemia. Surg Gyneco Obstet. 1988;167:103–108.
- Schoenberg MH, Beger HG. Oxygen radicals in intestinal ischemia and reperfusion. Crit Care Med. 1988;10:947–953.
- Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol. 1986;250:749–753.
- Park PO, Haglund U, Bulkley GB, The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 1990;107:574–580.
- Kong SE, Blennerhassett LR, Heel KA, Ischemia reperfusion injury to the intestine. Am J Med Sci. 1994;4:284–292.
- Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischemia. Crit Care Med. 1993;21:1376–1386.
- Floyd RA, Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol. 1992;32:22–27.
- López-Lázaro M. Distribution and biological activities of the flavonoid luteolin Mini. Rev Med Chem. 2009;9(1):31–59.
- Chevreul M. Luteolin. Principe colorant de la gaude. Journal de chimie médicale, de pharmacie et de toxicology 1830;6:157–159.
- Liao PH, Hung LM, Chen YH, Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats. Circ J. 2011;75(2):443–450.
- Cai Q, Rahn RO, Zhang R. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett. 1997;119(1):99–107.
- Odontuya G, Hoult JR, Houghton PJ. Structure-activity relationship for antiinflammatory effect of luteolin and its derived glycosides. Phytother Res. 2005;19(9):782–786.
- Ziyan L, Yongmei Z, Nan Z, Evaluation of the anti-inflammatory activity of luteolin in experimental animal models. Planta Med. 2007;73(3):221–226.
- Liu AL, Liu B, Qin HL, Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008;74(8):847–851.
- Das BB, Sen N, Roy A, Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I. Nucleic Acids Res. 2006;34(4):1121–1132.
- Lee EJ, Oh SY, Sung MK. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem Toxicol. 2012;50(11):4136–4143.
- Byun S, Lee KW, Jung SK, Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res. 2010;70(6):2415–2423.
- Inoue T, Sugimoto Y, Masuda H, Antiallergic effect of flavonoid glycosides obtained from Mentha piperita L. Biol Pharm Bull. 2002;25(2):256–259.
- Wang G, Li W, Lu X, Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy. J Diabetes Complicat. 2012;26(4):259–265.
- Zhao G, Zang SY, Jiang ZH, Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model. J Nutr Biochem. 2011;22(10):929–936.
- Kotanidou A, Xagorari A, Bagli E, Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. Am J Respir Crit Care Med. 2002;165(6):818–823.
- Rehrig S, Fleming SD, Anderson J, Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J Immunol. 2001;167(10):5921–5927.
- Chiu CJ, McArdle AH, Brown R, Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101:478–483.
- Quaedackers JS, Beuk RJ, Bennet L, An evaluation of methods for grading histologic injury following ischemia/reperfusion of the small bowel. Transplant Proc. 2000;32(6):1307–1310.
- Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–119.
- Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38:1103–1111.
- Phillips L, Toledo AH, Lopez-Neblina F, Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22(1):46–55.
- Albayrak Y, Halici Z, Odabasoglu F, The effects of testosterone on intestinal ischemia/reperfusion in rats. J Invest Surg. 2011;6:283–291.
- Terzi A, Coban S, Yildiz F, Protective effects of Nigella sativa on intestinal ischemia-reperfusion injury in rats. J Invest Surg. 2010;1:21–27.
- Ahlenstiel T, Burkhardt G, Köhler H, Improved cold preservation of kidney tubular cells by means of adding bioflavonoids to organ preservation solutions. Transplantation 2006;81(2):231–239.
- Anup R, Aparna V, Pulimood A, Surgical stress and the small intestine: role of oxygen free radicals. Surgery 1999;125(5):560–569.
- Yukioka T, Tanaka H, Ikegami K, Free radicals and surgical stress. Nihon Geka Gakkai Zasshi 1996;97(9):716–720.
- Sane AS, Chokshi SA, Mishra VV, Serum lipoperoxide levels in surgical stress of abdominal hysterectomy. Panminerva Med. 1993;35(3):131–133.
- Fang F, Li D, Pan H, Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion. Pharmacology 2011;88(3–4):149–158.
- Kim DS, Kwon DY, Kim MS, The involvement of endoplasmic reticulum stress in flavonoid-induced protection on cardiac cell death caused by ischaemia/reperfusion. J Pharm Pharmaco. 2010;62(2):197–204.